3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We previously reported a basic algorithm to identify the risk of Parkinson’s disease (PD) using published data on risk factors and prodromal features. Using this algorithm, the PREDICT-PD study identified individuals at increased risk of PD and used tapping speed, hyposmia and REM sleep behaviour disorder (RBD) as “intermediate” markers of prodromal PD in the absence of sufficient incident cases. We have now developed and tested an enhanced algorithm which incorporates the intermediate markers into the risk model. Risk estimates were compared using the enhanced and the basic algorithm in members of the PREDICT-PD pilot cohort. The enhanced PREDICT-PD algorithm yielded a much greater range of risk estimates than the basic algorithm (93–609-fold difference between the 10th and 90th centiles vs 10–13-fold respectively). There was a greater increase in the risk of PD with increasing risk scores for the enhanced algorithm than for the basic algorithm (hazard ratios per one standard deviation increase in log risk of 2.75 [95% CI 1.68–4.50; p < 0.001] versus 1.47 [95% CI 0.86–2.51; p = 0.16] respectively). Estimates from the enhanced algorithm also correlated more closely with subclinical striatal DaT-SPECT dopamine depletion ( R 2 = 0.164, p = 0.005 vs R 2 = 0.043, p = 0.17). Incorporating the previous intermediate markers of prodromal PD and using likelihood ratios improved the accuracy of the PREDICT-PD prediction algorithm.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          The cost of dichotomising continuous variables.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MDS research criteria for prodromal Parkinson's disease.

            This article describes research criteria and probability methodology for the diagnosis of prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD neurodegeneration are present, but classic clinical diagnosis based on fully evolved motor parkinsonism is not yet possible. Given the lack of clear neuroprotective/disease-modifying therapy for prodromal PD, these criteria were developed for research purposes only. The criteria are based upon the likelihood of prodromal disease being present with probable prodromal PD defined as ≥80% certainty. Certainty estimates rely upon calculation of an individual's risk of having prodromal PD, using a Bayesian naïve classifier. In this methodology, a previous probability of prodromal disease is delineated based upon age. Then, the probability of prodromal PD is calculated by adding diagnostic information, expressed as likelihood ratios. This diagnostic information combines estimates of background risk (from environmental risk factors and genetic findings) and results of diagnostic marker testing. In order to be included, diagnostic markers had to have prospective evidence documenting ability to predict clinical PD. They include motor and nonmotor clinical symptoms, clinical signs, and ancillary diagnostic tests. These criteria represent a first step in the formal delineation of early stages of PD and will require constant updating as more information becomes available.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Update of the MDS research criteria for prodromal Parkinson's disease

                Bookmark

                Author and article information

                Contributors
                a.noyce@qmul.ac.uk
                Journal
                NPJ Parkinsons Dis
                NPJ Parkinsons Dis
                NPJ Parkinson's Disease
                Nature Publishing Group UK (London )
                2373-8057
                1 April 2021
                1 April 2021
                2021
                : 7
                : 33
                Affiliations
                [1 ]GRID grid.4868.2, ISNI 0000 0001 2171 1133, Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, ; London, UK
                [2 ]GRID grid.83440.3b, ISNI 0000000121901201, Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, , University College London, ; London, UK
                [3 ]GRID grid.4868.2, ISNI 0000 0001 2171 1133, Barts and The London School of Medicine and Dentistry, Queen Mary University, ; London, UK
                [4 ]GRID grid.4868.2, ISNI 0000 0001 2171 1133, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, ; London, UK
                Author information
                http://orcid.org/0000-0002-3088-8616
                http://orcid.org/0000-0002-2476-4385
                http://orcid.org/0000-0002-9872-6680
                http://orcid.org/0000-0003-3027-5497
                Article
                176
                10.1038/s41531-021-00176-9
                8017005
                33795693
                540fa4f6-e2a2-4f8e-be6e-2125084f3c86
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 10 August 2020
                : 22 February 2021
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100000304, Parkinson’s UK;
                Award ID: G-1606
                Award ID: G-1606
                Award Recipient :
                Funded by: Parkinson’s UK
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                predictive markers,risk factors
                predictive markers, risk factors

                Comments

                Comment on this article